SchnelleMCatibogNZhangMNabeebaccusAAAndersonGRichardsDAet alEchocardiographic evaluation of diastolic function in mouse models of heart disease
once reconstituted, refrigerate at 28 C (35.646.4 F) and do not freeze the solution
Quick Takeaways Tesamorelin has robust clinical evidence for reducing visceral fat (15-17.5%), increasing lean mass (1.42 kg), and improving metabolic markers in human trials Ipamorelin selectively releases growth hormone without affecting cortisol or prolactin, making it the cleanest GHRP available Combining a GHRH with a GHRP creates synergistic GH pulsatility that mimics and amplifies your bodys natural growth hormone patterns My recommended protocol: Tesamorelin 1mg + Ipamorelin 100mcg, injected AM/PM, 5 days on/2 days off, 8 weeks on/8 weeks off What This Peptide Combination Actually Is Tesamorelin and Ipamorelin target different receptors in the growth hormone regulation system, which is precisely why they work so well together
Research around CJC-1295 and Ipamorelin includes experimental, investigational, and limited human-interest discussion, but evidence quality, clinical standards, and regulatory context can vary